- Home
- FCCO vs OBIO Comparison
FCCO vs OBIO Comparison
Compare FCCO & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCCO | OBIO |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.0M | 237.2M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | FCCO | OBIO |
|---|---|---|
| Price | $29.80 | $3.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 85.9K | ★ 203.8K |
| Earning Date | 01-28-2026 | 03-30-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | ★ 36.46 | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $78,007,000.00 | $2,818,000.00 |
| Revenue This Year | $30.67 | $36.66 |
| Revenue Next Year | $5.87 | $2.30 |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | ★ 19.77 | 6.46 |
| 52 Week Low | $19.46 | $2.20 |
| 52 Week High | $31.50 | $5.98 |
Technical Indicators
Market Signals| Indicator | FCCO | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 44.65 |
| Support Level | $30.61 | $3.62 |
| Resistance Level | $31.43 | $4.25 |
| Average True Range (ATR) | 0.75 | 0.34 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 55.15 | 45.86 |
Price Performance
Historical ComparisonAbout FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.